|
Volumn 17, Issue 5, 2013, Pages 570-571
|
Tuberculosis diagnostics: Test developers' FAQs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEDAQUILINE;
ANTIBIOTIC SENSITIVITY;
DEVELOPING COUNTRY;
DIAGNOSTIC KIT;
DIAGNOSTIC TEST;
EDITORIAL;
HEALTH CARE POLICY;
HUMAN;
INTERMETHOD COMPARISON;
LATENT TUBERCULOSIS;
MEDICAL DECISION MAKING;
POINT OF CARE TESTING;
PRIORITY JOURNAL;
QUESTIONNAIRE;
TUBERCULOSIS;
VALIDITY;
BACTERIOLOGICAL TECHNIQUES;
COMMERCE;
DIFFUSION OF INNOVATION;
FORECASTING;
HEALTH CARE COSTS;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MYCOBACTERIUM TUBERCULOSIS;
POINT-OF-CARE SYSTEMS;
PREDICTIVE VALUE OF TESTS;
QUALITY CONTROL;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
TUBERCULOSIS;
|
EID: 84876838368
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: 10.5588/ijtld.13.0036 Document Type: Editorial |
Times cited : (11)
|
References (6)
|